Author:
Pacheco C.,AlBadri A.,Anderson R.D.,Petersen J.,Marpuri S.,Cook-Wiens G.,Pepine C.J.,Mancini G.B.J.,Merz C.N. Bairey,Wei J.
Reference29 articles.
1. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch. Intern. Med. 2009;169:843–50.
2. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J. Am. Coll. Cardiol. 2010;55:2825–32.
3. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory
4. Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation;Nicholls;Cardiovasc. Diagn. Ther.,2018
5. Coronary microvascular dysfunction is associated with significant plaque burden and diffuse epicardial atherosclerotic disease;AlBadri;JACC Cardiovasc. Interv.,2019